APP and amyloidosis: DA5‐CH has shown good effects in the APP/PS1 mouse model of AD, rescuing memory formation, synaptic plasticity, and reducing the amyloid plaque load in the brain while normalizing PI3k and Akt activity, two kinases that are activate by insulin receptor activation (Cao et al., 2018).